@article {169,
	title = {Avoiding neuromuscular stimulation in liver irreversible electroporation using radiofrequency electric fields},
	journal = {Physics in Medicine and Biology},
	volume = {63},
	year = {2018},
	pages = {035027},
	chapter = {035027},
	doi = {10.1088/1361-6560/aaa16f},
	author = {Q. Castellv{\'\i} and Borja Mercadal and Xavier Moll and Fontdevila, Dolors and Andaluz, Anna and Antoni Ivorra}
}
@article {Jose2012,
	title = {{Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models.}},
	journal = {Cancer letters},
	volume = {317},
	number = {1},
	year = {2012},
	pages = {16{\textendash}23},
	abstract = {<p>Pancreatic ductal adenocarcinoma (PDAC) therapies show limited success. Irreversible electroporation (IRE) is an innovative loco-regional therapy in which high-voltage pulses are applied to induce plasma membrane defects leading to cellular death. In the present study we evaluated the feasibility of IRE against PDAC. IRE treatment exhibited significant antitumor effects and prolonged survival in mice with orthotopic xenografts. Extensive tumor necrosis, reduced tumor cell proliferation and disruption of microvessels were observed at different days post-IRE. Animals had transient increases in transaminases, amylase and lipase enzymes that normalized at 24h post-IRE. These results suggest that IRE could be an effective treatment for locally advanced pancreatic tumors.</p>
},
	keywords = {Alanine Transaminase, Alanine Transaminase: blood, Amylases, Amylases: blood, Animals, Aspartate Aminotransferases, Aspartate Aminotransferases: blood, Biological Markers, Biological Markers: blood, Blood Glucose, Blood Glucose: metabolism, Carcinoma, Cell Line, Cell Proliferation, Electrochemotherapy, Electrochemotherapy: adverse effects, Feasibility Studies, Genes, Humans, Lipase, Lipase: blood, Luminescent Measurements, Male, Mice, Microvessels, Microvessels: pathology, Necrosis, Nude, Pancreatic Ductal, Pancreatic Ductal: blood, Pancreatic Ductal: blood supply, Pancreatic Ductal: genetics, Pancreatic Ductal: pathology, Pancreatic Ductal: therapy, Pancreatic Neoplasms, Pancreatic Neoplasms: blood, Pancreatic Neoplasms: blood supply, Pancreatic Neoplasms: genetics, Pancreatic Neoplasms: pathology, Pancreatic Neoplasms: therapy, Reporter, Time Factors, Transfection, Tumor, Xenograft Model Antitumor Assays},
	issn = {1872-7980},
	doi = {10.1016/j.canlet.2011.11.004},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/22079741},
	author = {Jos{\'e}, Anabel and Sobrevals, Luciano and Antoni Ivorra and Fillat, Cristina}
}
